Oaktree Life Sciences Lending Fund (Parallel 2), L.P.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-11-0111/1/22 | Amended | $431,000,000 | $431,000,000 | Equity Only | 06b 3C 3C.7 | SEC linkSEC |
| 2021-09-039/3/21 | New | Yet to Sell | $0 | Equity Only | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| John Frank | Executive |
| Bruce Karsh | Executive |
| Daniel Levin | Executive |
| Howard Marks | Executive |
| Todd Molz | Executive |
| N/A Oaktree Capital Management, L.P. | Promoter |
| N/A Oaktree Life Sciences Lending Fund Gp, L.P. | Executive |
| Sheldon Stone | Executive |
| Jay Wintrob | Executive |
Industry: Pooled Investment Fund (See others in industry)
Address:
333 S. Grand Avenue 28 Th Floor
Los Angeles, CA, 90071
Phone: 213-830-6300
Los Angeles, CA, 90071
Phone: 213-830-6300